Inhibitory Activities of Gatifloxacin (AM-1155), a Newly Developed Fluoroquinolone, Against Bacterial and Mammalian Type II Topoisomerases
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.42.10.2678
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 1998
Authors
Publisher
American Society for Microbiology